AU4641097A - New pharmaceutical parenteral formulation of a thrombin inhibitor - Google Patents
New pharmaceutical parenteral formulation of a thrombin inhibitorInfo
- Publication number
- AU4641097A AU4641097A AU46410/97A AU4641097A AU4641097A AU 4641097 A AU4641097 A AU 4641097A AU 46410/97 A AU46410/97 A AU 46410/97A AU 4641097 A AU4641097 A AU 4641097A AU 4641097 A AU4641097 A AU 4641097A
- Authority
- AU
- Australia
- Prior art keywords
- thrombin inhibitor
- parenteral formulation
- new pharmaceutical
- pharmaceutical parenteral
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/005—Enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9603724 | 1996-10-11 | ||
SE9603724A SE9603724D0 (en) | 1996-10-11 | 1996-10-11 | New pharmaceutical parenteral formulation of a thrombin inhibitor |
PCT/SE1997/001652 WO1998016252A1 (en) | 1996-10-11 | 1997-10-01 | New pharmaceutical parenteral formulation of a thrombin inhibitor |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4641097A true AU4641097A (en) | 1998-05-11 |
Family
ID=20404213
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU46410/97A Abandoned AU4641097A (en) | 1996-10-11 | 1997-10-01 | New pharmaceutical parenteral formulation of a thrombin inhibitor |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU4641097A (en) |
SE (1) | SE9603724D0 (en) |
WO (1) | WO1998016252A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0955063A1 (en) * | 1998-04-01 | 1999-11-10 | Basf Aktiengesellschaft | Use of aqueous compositions in medicaments for subcutaneous or intramuscular administration |
SE9802973D0 (en) * | 1998-09-03 | 1998-09-03 | Astra Ab | Immediate release tablet |
SE9900070D0 (en) * | 1999-01-13 | 1999-01-13 | Astra Ab | New use |
SE9902202D0 (en) | 1999-06-10 | 1999-06-10 | Astra Ab | Production of aggregates |
SE9902550D0 (en) * | 1999-07-02 | 1999-07-02 | Astra Ab | New crystalline forms |
US6462021B1 (en) | 2000-11-06 | 2002-10-08 | Astrazeneca Ab | Use of low molecular weight thrombin inhibitor |
AR035216A1 (en) | 2000-12-01 | 2004-05-05 | Astrazeneca Ab | MANDELIC ACID DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE DERIVATIVES, USE OF THESE DERIVATIVES FOR THE MANUFACTURE OF MEDICINES, TREATMENT METHODS, PROCESSES FOR THE PREPARATION OF THESE DERIVATIVES, AND INTERMEDIARY COMPOUNDS |
SE0201659D0 (en) * | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | Modified release pharmaceutical formulation |
SE0201661D0 (en) | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | New salts |
DK1569912T3 (en) | 2002-12-03 | 2015-06-29 | Pharmacyclics Inc | 2- (2-hydroxybiphenyl-3-yl) -1h-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA724184B (en) * | 1971-07-14 | 1973-03-28 | Basf Wyandotte Corp | Stabilized blood composition |
US5306501A (en) * | 1990-05-01 | 1994-04-26 | Mediventures, Inc. | Drug delivery by injection with thermoreversible gels containing polyoxyalkylene copolymers |
SE9103612D0 (en) * | 1991-12-04 | 1991-12-04 | Astra Ab | NEW PEPTIDE DERIVATIVES |
SE9301916D0 (en) * | 1993-06-03 | 1993-06-03 | Ab Astra | NEW PEPTIDES DERIVATIVES |
-
1996
- 1996-10-11 SE SE9603724A patent/SE9603724D0/en unknown
-
1997
- 1997-10-01 WO PCT/SE1997/001652 patent/WO1998016252A1/en active Application Filing
- 1997-10-01 AU AU46410/97A patent/AU4641097A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1998016252A1 (en) | 1998-04-23 |
SE9603724D0 (en) | 1996-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4875196A (en) | Novel thrombin inhibitors | |
AU4787596A (en) | Thrombin inhibitors | |
AU3832895A (en) | Thrombin inhibitors | |
AU7497596A (en) | Thrombin inhibitors | |
AU4172397A (en) | Lactam inhibitors of thrombin | |
AU7145294A (en) | Heterocyclic thrombin inhibitors | |
AU2719597A (en) | New pharmaceutical formulation of a thrombin inhibitor for parenteral use | |
AU6352398A (en) | Bioadhesive tablets | |
EP0820453A4 (en) | Thrombin inhibitors | |
AU3102397A (en) | Metalloprotease inhibitors | |
AU3941797A (en) | Novel thrombin inhibitors | |
AU7038496A (en) | Angiogenesis inhibitor | |
AU7139598A (en) | Protease inhibitors | |
AU3459897A (en) | Differentiation inhibitor | |
AU1808999A (en) | Fibrinolytic inhibitor for sealant | |
AU692123B2 (en) | 5alpha-reductase inhibitors | |
AU6183494A (en) | Guanidinyl- or amidinyl-substituted heterocyclic thrombin inhibitors | |
AU4641097A (en) | New pharmaceutical parenteral formulation of a thrombin inhibitor | |
AU3551297A (en) | Polymerisation inhibitor | |
AU2277597A (en) | New inhibitors of sh2-mediated processes | |
AU3396697A (en) | Thrombin inhibitor | |
AU4128597A (en) | Phosphatidylcholine synthesis inhibitors | |
AUPM982594A0 (en) | HIV protease inhibitors | |
AU9640698A (en) | Pharmaceutical combination of a cyclooxigenase-2 inhibitor and acetaminophen or an opiate | |
AU7398794A (en) | 7-substituted-delta4-6-azasteroid derivatives as 5alpha-reductase inhibitors |